Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

48.000
-0.440-0.91%
Volume:7.08M
Turnover:338.60M
Market Cap:318.58B
PE:34.69
High:49.100
Open:48.980
Low:46.480
Close:48.440
52wk High:88.043
52wk Low:43.020
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:1.86
T/O Rate:2.75%
Dividend:0.23
Dividend Rate:0.49%
EPS(LYR):1.384
ROE:12.46%
ROA:7.02%
PB:4.21
PE(LYR):34.69
PS:8.67

Loading ...

BlackRock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 5.76% on Oct 6 from 6.34% - HKEX

THOMSON REUTERS
·
Oct 09

HENGRUI PHARMA: Citigroup Inc. Acquires Shares, Long Position Rises to 5.24%

HK Disclosure
·
Oct 09

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 5.76%

HK Disclosure
·
Oct 09

Hengrui Pharma's Prostate Cancer Drug Gets European Approval

MT Newswires Live
·
Oct 09

Movement Alert|HENGRUI PHARMA Falls 3.43% in Regular Trading, Hong Kong Innovative Drug Sector Under Broad Pressure

Market Focus
·
Oct 09

HENGRUI PHARMA: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 9.87%

HK Disclosure
·
Oct 08

HENGRUI PHARMA Has Repurchased 585,000 A Shares as of the End of September

Stock News
·
Oct 08

HENGRUI PHARMA: The Capital Group Companies, Inc. Disposes of Shares, Long Position Falls to 10.96%

HK Disclosure
·
Oct 08

Movement Alert|HENGRUI PHARMA Intraday Rise 3.68%, Buyback and Immunology Pipeline Optimism Drive Gains

Market Focus
·
Oct 08

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 5.96%

HK Disclosure
·
Oct 06

BlackRock's Long Position in H-Shares of Jiangsu Hengrui Increases to 6.99% on Sept 30 from 5.96% - HKEX

THOMSON REUTERS
·
Oct 05

UBS Group Ag's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 4.59% on Sept 25 from 5.17% - HKEX

THOMSON REUTERS
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 5.96%

HK Disclosure
·
Oct 02

HENGRUI PHARMA: UBS Group AG Disposes of Shares, Long Position Falls to 4.59%

HK Disclosure
·
Oct 02

Movement Alert|HENGRUI PHARMA Falls 3.27% in Regular Trading, Profit-Taking After Novo Nordisk Deal Rally Amid Broad Pharma Sector Weakness

Market Focus
·
Oct 02

Hong Kong Stocks Close Higher as Property Stimulus Fails to Enthuse; Pharma Emerges as Safe Haven

Stock News
·
Sep 30

Daiwa: Hengrui Pharma (01276) Reaches Licensing Deal with Novo Nordisk for HRS-1596; Total Transaction Value and Upfront Payment Both Attractive

Stock News
·
Sep 30

Morgan Stanley Maintains Overweight Rating on Hengrui Pharma (01276) with HK$82 Target Price

Stock News
·
Sep 30

AI Drug Discovery Sector Heats Up: ChinaAMC Hang Seng Biotech (03069) Rises Over 4% Intraday, ChinaAMC Innovative Drugs (03525) Gains Over 3% in Afternoon Session

Stock News
·
Sep 30